The company
RenovoRx, Inc.
RNXT · Nasdaq
RNXT stood above a rising 150-day average in 12 of the last 52 weekly readings, including each of the last 11 weeks. It is 0.4% above that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Just started moving
- Weeks in an uptrend
- 11 in a row
- Industry in uptrend
- 15% -17 in 4 wk
- Insider buys, 12 months
- $123K
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 29 (-1)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 12 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Mark VollChief Financial Officer | bought | 25,000at $0.7876 | 19 May 2026filed 21 May 2026 |
| Mark VollChief Financial Officer | bought | 97,200 | 20 Mar 2026filed 24 Mar 2026 |
| Mark VollChief Financial Officer | bought | 48,600 | 20 Mar 2026filed 24 Mar 2026 |
| Shaun BagaiChief Executive Officer | bought | 24,300 | 20 Mar 2026filed 24 Mar 2026 |
| Shaun BagaiChief Executive Officer | bought | 12,150 | 20 Mar 2026filed 24 Mar 2026 |
| Laurence MartonDirector | bought | 9,720 | 20 Mar 2026filed 24 Mar 2026 |
| Laurence MartonDirector | bought | 4,860 | 20 Mar 2026filed 24 Mar 2026 |
| Ramtin AgahChief Medical Officer | bought | 10,000at $0.9975 | 21 Jan 2026filed 22 Jan 2026 |
| Ramtin AgahChief Medical Officer | bought | 9,795at $0.86 | 31 Dec 2025filed 5 Jan 2026 |
| Ramtin AgahChief Medical Officer | bought | 205at $0.826 | 30 Dec 2025filed 2 Jan 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| AIGH Capital Management LLCadded · filed 7 Aug 2026 | 4,405,439$4.3M | +699,242+18.9% |
| Bleichroeder LPunchanged · filed 13 Aug 2026 | 1,666,098$1.6M | 00.0% |
| VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026 | 1,443,742$1.4M | -3,435−0.2% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 424,148$416K | +42,425+11.1% |
| Wealthspire Advisors, LLCunchanged · filed 11 Aug 2026 | 252,525$247K | 00.0% |
| VANGUARD FIDUCIARY TRUST COadded · filed 13 Aug 2026 | 240,330$236K | +82,428+52.2% |
| CITADEL ADVISORS LLCreduced · filed 14 Aug 2026 | 133,597$131K | -99,087−42.6% |
| Chicago Partners Investment Group LLCunchanged · filed 30 Jul 2026 | 92,356$79K | 00.0% |
| NORTHERN TRUST CORPadded · filed 13 Aug 2026 | 85,207$84K | +43,046+102.1% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT COreduced · filed 12 Aug 2026 | 74,596$73K | -24,864−25.0% |
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.